Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosine

This publication has 25 references indexed in Scilit:

• Multiple drug effect analysis with confidence interval
  Antiviral Research, 1994
• Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy
  Journal of General Virology, 1994
• Combination Therapy for Infection Due to Human Immunodeficiency Virus Type 1
  Clinical Infectious Diseases, 1994
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
  Expert Opinion on Investigational Drugs, 1994
• Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro
  Antimicrobial Agents and Chemotherapy, 1994
• HIV resistance to reverse transcriptase inhibitors
  Biochemical Pharmacology, 1994
• Knocking-Out Concentrations of HIV-1-Specific Inhibitors Completely Suppress HIV-1 Infection and Prevent the Emergence of Drug-Resistant Virus
  Virology, 1993
• Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors.
  Proceedings of the National Academy of Sciences, 1993
• Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy
  Nature, 1993
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
  Advances in Enzyme Regulation, 1984